Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-22

FDA Approved: LEVALBUTEROL — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Mylan's original ANDA for levalbuterol hydrochloride, a generic inhaled bronchodilator indicated for reversible obstructive airway disease such as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levalbuterol hydrochloride (Levalbuterol hydrochloride)

Snippet

ORIG AP for LEVALBUTEROL (LEVALBUTEROL)